Q32 Bio Inc. (QTTB) Short term Debt (2023 - 2026)

Q32 Bio has reported Short term Debt for 4 years, with the latest figure at $6.2 million in Q1 2026.

• On a quarterly basis, Short term Debt rose 33.83% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was $6.2 million, a 33.83% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 101.32% from the prior year.
• Short term Debt was $6.2 million for Q1 2026 at Q32 Bio, roughly flat from $6.2 million in the prior quarter.
• The five-year high for Short term Debt was $6.2 million in Q1 2026, with the low at $878000.0 in Q4 2023.
• Average Short term Debt over 4 years is $4.2 million, with a median of $4.7 million recorded in 2025.
• The sharpest annual moves came in 2025 and 2026: Short term Debt soared 306.52% in 2025, then soared 33.83% in 2026.
• Over 4 years, Short term Debt stood at $878000.0 in 2023, then surged by 252.73% to $3.1 million in 2024, then surged by 101.32% to $6.2 million in 2025, then climbed by 0.06% to $6.2 million in 2026.
• The last three Short term Debt figures came in at $6.2 million (Q1 2026), $6.2 million (Q4 2025), and $6.2 million (Q3 2025), per Business Quant data.